Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

Click for more information

0.00%

1.4¢ chimeric therapeutics limited

Thinking.., page-22

First 22 Last

Share
Profile

Follow
zmans

14,698 Posts.

1505

02/07/21

21:52

Post #: 54251875
Share

Originally posted by stockrock: ↑

Chimeric has 330,526,401 shares on issue, which even after today's rise to 36.5cents put it at a market cap of A$120.6m

IMU currently has 5.0bn shares on issue, and if we multiply that by 2.9cents.. that would equate to a comparable entry of A$144.0m.

Back in 2019 IMU had approx 3.6bn shares, so if that is when you bought in the market cap would have been approx A$104.0m.

If you take away today's rise in CHM, we were trading around 30 cents which would put us at a market cap of A$99.2m.

So it looks like CHM at this price range is quite comparable to buying IMU at 2.9 cents... and I am very confident CHM will rival and in my opinion, overtake IMU's market cap in the years to come.

One thing to be aware of is that CHM will at some stage need to raise capital, however the next cap raise is not expected until mid to late 2022.. which means we'll have plenty of phase I data to excite the market and lift the share price to a much less dilutive capital raise.

IMU did most of it's capital raising when it was in the 2 cent / A$100m range... which is something CHM has a good chance of avoiding.

goodluck all

Expand

Great summation, the way I see it is based on current cash burn and cash in bank they have another 8-9 quarters funding.

CHM Price at posting: 36.5¢ Sentiment: None Disclosure: Not Held
3 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

There are more pages in this discussion • 44 more messages in this thread...

First 22 Last

Add CHM (ASX) to my watchlist